Boston Scientific Announces Results For First Quarter 2021
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- US futures fall on tech selloff as concerns about hawkish Fed, AI spending mount
- SpaceX extends losses after $600 billion wipeout, tech stocks slide again
- Oil steady as investors focus on Hormuz flows after peace talks
- South Korea leveraged ETF crisis sparks global chip selloff
- Trump announces nuclear deal with Iran, lifts Hormuz blockade
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
- 'Equal and opposite': BTIG's Krinsky sees sharp reversal ahead for chip stocks
Boston Scientific (BSX) PT Raised to $48 at BTIG
April 28, 2021 1:17 PM EDTBTIG analyst Marie Thibault raised the price target on Boston Scientific (NYSE: BSX) to $48.00 (from $44.00) while maintaining a Buy rating.
The analyst commented, "Despite what we felt were high expectations for Boston Scientifics Q1 print, the company easily beat consensus estimates and exceeded the high end of the guidance range. BSX also posted y/y growth over 2019 comps and... More
Boston Scientific (BSX) PT Raised to $51 at Piper Sandler Following Earnings
April 28, 2021 11:30 AM EDTPiper Sandler analyst Matt O'Brien raised the price target on Boston Scientific (NYSE: BSX) to $51.00 (from $46.00) while maintaining an Overweight rating.
... MoreBoston Scientific (BSX) Tops Q1 EPS by 6c, Offers Guidance
April 28, 2021 6:32 AM EDTBoston Scientific (NYSE: BSX) reported Q1 EPS of $0.37, $0.06 better than the analyst estimate of $0.31. Revenue for the quarter came in at $2.75 billion versus the consensus estimate of $2.62 billion.
GUIDANCE:
Boston Scientific sees Q2 2021 EPS of $0.36-$0.38, versus the consensus of $0.35.
The company now estimates net sales growth for the full year 2021, versus the prior year period, to be in a... More